RA CAPITAL MANAGEMENT, L.P. Q4 2019 Filing

Filed February 14, 2020

Portfolio Value

$3.3T

Holdings

34

Report Date

Q4 2019

Filing Type

13F-HR

All Holdings (34 positions)

#StockSharesValue% PortfolioType
1
SYNTHORX INC
9,724,598$679.7B20.61%
2
ASNDASCENDIS PHARMA A S
4,185,342$582.3B17.66%
3
RA PHARMACEUTICALS INC
4,858,260$228.0B6.91%
4
ARVNARVINAS INC
3,672,872$150.9B4.58%
5
CCXIEURCHEMOCENTRYX INC
3,199,389$126.5B3.84%
6
RYTMRHYTHM PHARMACEUTICALS INC
5,422,312$124.5B3.78%
7
EIDOS THERAPEUTICS INC
2,162,671$124.1B3.76%
8
ZOGENIX INC
2,260,751$117.9B3.57%
9
PHATPHATHOM PHARMACEUTICALS INC
3,646,808$113.6B3.44%
10
TGTXTG THERAPEUTICS INC
9,880,323$109.7B3.33%
11
SATSUMA PHARMACEUTICALS INC
4,681,858$92.1B2.79%
12
ORTXUSDORCHARD THERAPEUTICS PLC
6,389,901$87.9B2.66%
13
ETNBGBP89BIO INC
3,161,214$83.1B2.52%
14
FORTY SEVEN INC
1,933,250$76.1B2.31%
15
WVEWAVE LIFE SCIENCES LTD
7,775,207$62.3B1.89%
16
RETROPHIN INC
4,252,453$60.4B1.83%
17
AUDENTES THERAPEUTICS INC
902,383$54.0B1.64%
18
PREVAIL THERAPEUTICS INC
3,363,605$53.2B1.61%
19
CRNXCRINETICS PHARMACEUTICALS INC
1,875,209$47.0B1.43%
20
ARDXARDELYX INC
5,358,863$40.2B1.22%
21
AXSMAXSOME THERAPEUTICS INC
367,816$38.0B1.15%
22
1K0IGM BIOSCIENCES INC
982,723$37.5B1.14%
23
STOKSTOKE THERAPEUTICS INC
1,119,963$31.7B0.96%
24
RLMDRELMADA THERAPEUTICS INC
761,666$29.7B0.90%
25
MOMENTA PHARMACEUTICALS INC
1,445,801$28.5B0.87%
26
SLDBSOLID BIOSCIENCES INC
4,571,164$20.3B0.62%
27
SCPHSCPHARMACEUTICALS INC
3,247,005$18.4B0.56%
28
ALECALECTOR INC
1,000,000$17.2B0.52%
29
KALAKALA PHARMACEUTICALS INC
4,537,478$16.7B0.51%
30
GRTXGALERA THERAPEUTICS INC
1,054,178$13.9B0.42%
31
DVAXDYNAVAX TECHNOLOGIES CORP
2,365,912$13.5B0.41%
32
PORTOLA PHARMACEUTICALS INC
429,399$10.3B0.31%
33
EPIEURESSA PHARMA INC
1,000,000$5.5B0.17%
34
ASNSUSDX4 PHARMACEUTICALS INC
270,292$2.9B0.09%